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The Expanding Toolkit of Translating Ribosome Affinity
Purification
X Joseph D. Dougherty
Departments of Genetics and Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110
Translating ribosome affinity purification is a method initially developed for profiling mRNA from genetically defined cell types in
complex tissues. It has been applied both to identify targetmolecules in cell types that are important for controlling a variety of behaviors
in the brain, and to understand the molecular consequences on those cells due to experimental manipulations, ranging from drugs of
abuse to disease-causingmutations. Since its inception, a variety of methodological advances are opening new avenues of investigation.
These advances include a variety of newmethods for targeting cells for translating ribosome affinity purification by features such as their
projections or activity, additional tags andmouse reagents increasing the flexibility of the system, and newmodifications of themethod
specifically focused on studying the regulation of translation. The latter includes methods to assess cell type-specific regulation of
translation in specific subcellular compartments. Here, I provide a summary of these recent advances and resources, highlighting both
new experimental opportunities and areas for future technical development.
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Introduction
The CNS is composed of hundreds of distinct cell types. Yet, as is
clear from the example of Parkinson’s disease, disorders of the
CNS can be caused by disruptions of just a single one. And be-
cause all cell types contain an identical copy of the genome, dis-
tinct cell types must be defined by the portions of their genomes
that are expressed. However, as these cell types are densely inter-
mingled, dissociating them to assay specific types for gene ex-
pression analysis, especially from adult tissues, is challenging. To
circumvent this challenge Heiman et al. (2008) developed strat-
egies to purify ribosomes from specific, genetically labeled CNS
cell types (Fig. 1A). As all protein-coding mRNAs used in a cell
are processed by the ribosome, harvesting cell-specific tagged
ribosomes allows for quantitative and high throughput analysis
of gene expression from the targeted cells.
While translating ribosome affinity purification (TRAP) has
clear applications for simply assessing gene expression, it should
also be emphasized that ribosome capture allows for study of cell
type-specific regulation of translation. Here, I briefly review the
original applications of TRAP, primarily for either in-depth mo-
lecular characterizations of cell types or assessment of cell type-
specific responses to whole-animal experimental manipulations.
Then I summarize subsequent innovations enabling wider
applications. Finally, I highlight emerging variations of TRAP
that focus on the unique opportunities for analyzing translational
regulation.
Initial application
In-depth molecular descriptions of genetically labeled
cell types
Themost straightforward application of TRAP is for comprehen-
sive profiling of the mRNA usage of the targeted cell type. When
TRAPwas first applied to survey CNS cell types (Doyle et al., 2008),
the diversity in gene expression was remarkable. A comparison of
any two cell types via TRAP revealed thousands of differences in
transcript abundance. And while neurons and glia clustered sepa-
rately, there was as much diversity across neuronal types as there
was between neurons and glia.While genes classically considered
“housekeeping,” such as metabolic enzymes or ribosomal pro-
teins, might vary in abundance 2- to 3-fold across cell types,
signaling molecules, particularly cell surface proteins, such as
receptors and channels, often varied10-fold. Thus, TRAP as a
descriptive method can provide insight into the molecules that
define a given cell type.
There were several clear implications of this dramatic diver-
gence of expression across cell types. First, on a practical level, the
large-magnitude changes mean that a relatively small number of
replicates are sufficient to define transcripts enriched in a partic-
ular cell type (“markers”). Even with 1–3 replicates, transcripts
with marker-like expression were readily identified. Indeed, esti-
mates using RNAseq power (Hart et al., 2013) indicate that, even
with a single replicate sequenced to 25 million reads, one has
80% power to detect a gene with a “marker-like” 5-fold differ-
ence between two cells types (and 98% power to detect a 10-fold
difference). Second, on a scientific level, the diversity of expres-
sion implied that different cell types have markedly different ca-
pacities to respond to extracellular ligands, contributing to the
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complexity by which different classes of cells might convey infor-
mation to each other. This diversity of ligand/receptor pairs
allows for overlapping information processing networks in the
same physical space. Third, it suggested that transcriptomics has
sufficient information to define a cellular taxonomy for CNS
(Dougherty, 2014), an idea that is being tested now by initia-
tives in brainwide transcriptome cell atlases. Finally, it suggested
that the relationship between gene expression and cell typemight
inform our understanding of neurogenetics of normal and ab-
normal behavior, based on the “selective expression” hypothesis
(Lage et al., 2008; Xu et al., 2014; Wells et al., 2015) that genes
important for a particular phenotype/disease will have enriched
expression in the cell types that mediate that phenotype/disease.
Studies based on this premise have been applied to better under-
stand both the cells and the genes that matter for particular
behaviors.
In one such approach, a “candidate cell type” (a cell type with
suspected involvement for the phenotype) is profiled. Enriched
transcripts are defined and then manipulated to determine im-
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Figure 1. Alternative methods for targeting cell types for TRAP. A, Illustration of standard TRAP work flow. A specific population of cells is driven to express a GFP-ribosomal fusion protein
(GFP/RPL10A, green) that allows for immunofluorescence to confirm targeting andprovides a tag for affinity purification of ribosomes from the targeted cell types byusing anti-GFPmagnetic beads.
Initially, cells were targeted using bacterial artificial chromosomes with known expression patterns (Table 1). B, A variety of mouse lines (Table 2) now allow GFP/RPL10A or related construct
expression in response to the presence of Cre recombinase,which removes a stop cassette flanked by LoxP sites. This allows profiling of the cell types froma large number of existing Cremouse lines.
C, Use of Cre-dependent virus constructs (here illustrated as the double-inverted operon or FLEX cassette, which flips into forward orientation in the presence of Cre), allows access to Cre-expressing
cells in specific regions of the adult brain. D, GFP/RPL10A can also be electroporated into the brain at a defined point in development to label a synchronized population of cells born in a particular
window. E, Use of a GFP/RPL10A reporter mouse and an activity-dependent inducible Cre allows for profiling of cells activated by a specific behavior. F, Use of a generic neuronal promoter and a
retrogradely infecting virus can be used to profile cells based on their projections. G, Coupling with transsynaptic viruses allows for profiling of second-order (or greater) neurons for a given region
and/or cell type.
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implicated in the sleep disorder narcolepsy, identified enriched
expression of Lhx9 in these cells. Subsequently, deletions of Lhx9
demonstrated a conserved role inmodulatingHcrt neuron num-
ber and sleep behavior (Dalal et al., 2013; Liu et al., 2015). Nu-
merous similar studies have defined cells and genes that mediate
depressive behavior (Schmidt et al., 2012; Shrestha et al., 2015),
communicative behavior (Dougherty et al., 2013), nicotinic re-
lapse (Go¨rlich et al., 2013), vulnerability to neurodegeneration
(Brichta et al., 2015; McKeever et al., 2017), sociosexual behavior
(Nakajima et al., 2014), chromatin modifiers of cerebellar devel-
opment (Yang et al., 2016; X. Zhu et al., 2016), and glial and
lymphoblast genes for development, injury, and repair (Dough-
erty et al., 2012; Lee et al., 2012; Anderson et al., 2016; Y. Zhu et
al., 2017). This approach has even expanded beyond the nervous
system to candidate cell types in brown fat (Long et al., 2014) and
kidneys (Liu et al., 2014). As TRAP has progressed frommicroar-
rays to RNAseq, even particular splice isoforms are being associ-
ated with specific cellular phenotypes: the c2 isoform of Pcdha
regulates axon tiling of serotonin neurons (W. V. Chen et al.,
2017), and differences inNrxn splicingmediate postsynaptic spe-
cializations across hippocampal cell types (Nguyen et al., 2016).
Thus, TRAP, through the lens of a candidate cell type frame-
work, can help identify transcripts important for phenotypes
of interest.
Assessment of cell type-specific responses to experimental
manipulations
The first TRAP experiment highlights the other major applica-
tion of TRAP, to understand how a targeted cell type responds to
an animal-wide manipulation: Heiman et al. (2008) used TRAP
to define the responses of two subtypes of striatal neurons to
cocaine. Recent studies have taken a similar approach to under-
standing consequences of L-Dopa (Heiman et al., 2014), stress or
LTP in hippocampal neurons (P. B. Chen et al., 2017), or sleep
and epilepsy in glia (Bellesi et al., 2015; Clasadonte et al., 2016).
Likewise, TRAP from mutant models allowed an understanding
of the cellular consequences of disease-causing mutations. These
might be particularly informative for mutations in RNA binding
proteins (Galloway et al., 2014; Tan et al., 2016) or transcriptional
regulators (Rannals et al., 2016; von Schimmelmann et al., 2016),
where a robust response might be expected in mRNA.
Two trends are apparent across these studies. First, TRAP has
sufficient reproducibility to identify cell type-specific conse-
quences of thesemanipulations. Second, however,magnitudes of
these within-cell type responses are generally substantially smaller
than magnitudes of the between-cell type differences. Philosophi-
cally, this implies that cell identity is a stronger driver of gene
expression than cell state. Practically, this means that these
studies need to be well powered to reliably detect these smaller
differences. For example, to be 80% powered to detect a twofold
difference between conditions within a cell type, one would need
at least 5 or 6 samples per condition. Careful balancing of poten-
tial confounds, both biological and technical, is essential. Expec-
tations regarding the number and magnitude of transcriptional
responses should be moderated.
Despite this and other challenges, TRAP has been widely ap-
plied, perhaps because it is more readily scalable than FACS or
laser capturemicrodissection. It will be interesting to see whether
newer nuclei-purification based approaches (Kriaucionis and
Heintz, 2009; Deal and Henikoff, 2010; Roh et al., 2017) show
similar successes, as they also circumvent the challenge dissociating
live single cells from complex CNS tissue. Likewise, true single-cell
approaches, such as DROPseq (Macosko et al., 2015), appear suffi-
ciently sensitive to identify the large-magnitude differences between
cell types (“marker-like” gene expression). However, there are such
rapid advances that it is difficult to estimate what the power of the
current methods might be for detecting subtle changes within a
given cell type in response tomanipulations. Power simulations do
currently indicate that, across methods as one assesses 100–200
cells for a given cell type, there is also sufficient power to detect
the differences between related subtypes of cells (i.e., different
typesofmicroglia) (Ziegenhainet al., 2017).Regardless, as single-cell
methods improve, they will likely supplant TRAP for some appli-
cations. Particularly for counting numbers of given cell types, the
ability to conduct DROPseq-like approaches on untagged cells
allows substantial experimental scalability. Yet, emerging appli-
cations for TRAP are enabling investigation of new experimental
questions, particularly around regulation of translation, for
which there is not yet a single-cell equivalent. These emerging
approaches are highlighted below.
Application
Targeting additional cell types defined by genetics,
projections, or activity
The initial bacTRAP mouse lines benefitted from a GENSAT-
defined set of bacterial artificial chromosomes to label specific,
genetically defined, cell types in the brain. While bacterial artifi-
cial chromosomes have advantages and disadvantages (Dough-
erty, 2014; Ting and Feng, 2014), these reagents enabled profiling
many cell types and remain publicly available (Table 1). In
addition, Cre-dependent reporter lines (Table 2; Fig. 1B) were
developed and enable TRAP of Cre-defined cell types. The
earliest reporter was the Ribotag mouse (Sanz et al., 2009). It
differs from traditional TRAP in that it generates a Cre-dependent
HA-tag on the endogenous RPL22 protein (Fig. 2A). While both
GFP/RPL10A and RPL22/HA tag the large subunit, differences in
relative stoichiometry and affinity of ribosomes for tagged pro-
teins, as well as antibody affinities, might lead to differences in
performance in vivo between the constructs. Likewise, recent
work has shown that RPL10A, at least in ES cells, is present at
substoichiometric levels, and ribosomes containing RPL10A
have altered affinity for 5% of transcripts (Shi et al., 2017).
While this will not likely influence comparisons between cell
types all tagged with GFP/RPL10A, as such biases should cancel
out; it may lead to interesting differences between the distinct
epitope tags. Thus, a direct comparison would be of both scien-
tific and technical interest. A variety of reporter lines expressing
GFP/RPL10A in a Cre-dependent (Zhou et al., 2013; Liu et al.,
2014) orTet-dependent (Drane et al., 2014)manner fromRosa26
or alternate loci (Stanley et al., 2013), even with alternate red
fluorophores as tags (Hupe et al., 2014) are available.
Also, TRAP constructs are small enough to package into adeno-
associated virus (Fig. 1C). Coupling a Cre-dependent FLEX design
and stereotactic injection allows for expression in spatially, tem-
porally, and genetically restricted cell populations (Nectow et al.,
2017). There are real advantages to delivering the TRAP con-
structs by adeno-associated virus for many cell types. Notably
viral expression takes weeks (compared with months for mouse
breeding), and may also circumvent well-known problems with
transient developmental Cre expression inmanymouse lines.
In addition, viral constructs allow for additional innovations
in targeting cell types based not only on specific Cre expression,
but also potentially by projections, location, and activity (Fig. 1).
For example, packaging with capsid proteins that infect axons at
their target zones allowed for molecular phenotyping of neurons
projecting to particular regions (Cook-Snyder et al., 2015), or
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when coupled with transsynaptic viruses, mapped inputs farther
upstream (Ekstrand et al., 2014; Pomeranz et al., 2017). Making
expression dependent on activity-dependent promoters allowed
for molecular phenotyping of cells activated by particular stimuli
(Ye et al., 2016). Yet another approach involves capturing ribo-
somes with a phosphorylated S6 protein (Fig. 2), a mark that can
be deposited on ribosomes by neuronal activity (Knight et al.,
2012). These “discovery-driven” studies, based on activity or pro-
jection, contrast with the candidate cell type studies where the
targeted cell type is selected a priori by marker gene expression.
Thus, they require a different perspective on analysis. Cell iden-
tity, defined by projection or activity, may not have a one to one
correspondence to cell type defined by gene expression. For ex-
ample, Pomeranz et al. (2017) clearly identified transcripts
known to be expressed inmultipledisparate cell typesbasedon their
projections to the VTA. Approaches leveraging prior molecular de-
scriptions of cell types may help interpret these results (Xu et al.,
2014). Also, because TRAP is a measure of the aggregate expres-
Table 1. List of publicly available bacTRAP linesa
Stock # Name Targeted cells Reference
030273 B6;FVB-Tg (Snap25-EGFP/Rpl10a)JD362Htz/J All neurons Dougherty et al., 2012
030247 B6;FVB-Tg (Aldh1l1-EGFP/Rpl10a)JD130Htz/J Astrocytes and other Aldh1L1 cells Doyle et al., 2008
030248 B6;FVB-Tg (Aldh1l1-EGFP/Rpl10a)JD133Htz/J Astrocytes and other Aldh1L1 cells Doyle et al., 2008
030271 B6;FVB-Tg (Sept4-EGFP/Rpl10a)DS152Htz/J Bergmann glia and other Sept4 cells Doyle et al., 2008
009159 B6;FVB-Tg (Cnp-EGFP/Rpl10a)JD368Htz/J Mature oligodendrocytes Doyle et al., 2008
030268 B6;FVB-Tg (Pdgfra-EGFP/Rpl10a)JD340Htz/J Oligodendrocyte progenitors and other Pdgfra cells Dougherty et al., 2012
030265 B6;FVB-Tg (Olig2-EGFP/Rpl10a)JD97Htz/J Oligodendroglia and other Olig2 cells Doyle et al., 2008
030251 B6;FVB-Tg (Cmtm5-EGFP/Rpl10a)JD307Htz/J Weakly positive in oligodendrocytes Doyle et al., 2008
030249 B6;FVB-Tg (Cck-EGFP/Rpl10a)GM391Htz/J Cck cells Doyle et al., 2008
030258 B6;FVB-Tg (Grm2-EGFP/Rpl10a)JP77Htz/J Cerebellar Golgi neurons and other Grm2 cells Doyle et al., 2008
030262 B6;FVB-Tg (Neurod1-EGFP/Rpl10a)JP241Htz/J Cerebellar granule neurons and other Neurod1 cells Doyle et al., 2008
030260 B6;FVB-Tg (Lypd6-EGFP/Rpl10a)JP48Htz/J Cerebellar stellate/basket neurons and other Lypd6 cells Doyle et al., 2008
030252 B6;FVB-Tg (Cort-EGFP/Rpl10a)GM130Htz/J Cortical Cort interneurons and other Cort cells Doyle et al., 2008; Nakajima et al., 2014
030261 B6;FVB-Tg (Nek7-EGFP/Rpl10a)MN733Htz/J Cortical Pvalb interneurons and other Nek7 cells Nakajima et al., 2014
030253 B6;FVB-Tg (Dlx1-EGFP/Rpl10a)GM520Htz/J Cortical SST and VIP interneurons, other Dlx1 cells Nakajima et al., 2014
030272 B6;FVB-Tg (Slc6a3-EGFP/Rpl10a)JD1640Htz/J Dopaminergic neurons Dougherty, 2017
012365 C57BL/6N-Tg (Slc6a3-EGFP/Rpl10a)I17-11Pggd/J Dopaminergic neurons Brichta et al., 2015
030254 B6;FVB-Tg (Drd1a-EGFP/Rpl10a)CP73Htz/J Drd1 medium spiny neurons and other Drd1 cells Heiman et al., 2008
030255 B6;FVB-Tg (Drd2-EGFP/Rpl10a)CP101Htz/J Drd2 medium spiny neurons and other Drd2 cells Heiman et al., 2008
028619 B6;FVB-Tg (Hcrt-EGFP/Rpl10a)JD218Jdd/J Hypocretin neurons Dalal et al., 2013
030264 B6;FVB-Tg (Ntsr1-EGFP/Rpl10a)TS16Htz/J Layer 6 neurons and other Ntsr1 cells Doyle et al., 2008
030263 B6.FVB-Tg (Ntf3-EGFP/Rpl10a)PS1046Htz/J Layer 2/3 neurons and other Ntf3 cells Shrestha et al., 2015
030257 B6.FVB (Cg)-Tg (Colgalt2-EGFP/Rpl10a)DU9Htz/J Layer 5b and other Colgalt2 (also known as Glt25d2) cells Doyle et al., 2008
030270 B6;FVB-Tg (S100a10-EGFP/Rpl10a)ES691Htz/J Layer 5a and other S100a10 cells Schmidt et al., 2012
030256 B6;FVB-Tg (Etv1-EGFP/Rpl10a)TS88Htz/J Mixed projection neurons and immune/microglial cells Doyle et al., 2008
030250 B6.FVB (Cg)-Tg (Chat-EGFP/Rpl10a,Slc18a3)DW167Htz/J Motor neurons and other cholinergic cells Doyle et al., 2008
030269 B6;FVB-Tg (Pnoc-EGFP/Rpl10a)GM64Htz/J Pnoc interneurons and other Pnoc cells Doyle et al., 2008
030266 B6;FVB-Tg (Pcp2-EGFP/Rpl10a)DR166Htz/J Purkinje neurons Doyle et al., 2008
030267 B6;FVB-Tg (Pcp2-EGFP/Rpl10a)DR168Htz/J Purkinje neurons Doyle et al., 2008
028620 B6;FVB-Tg (Slc6a4-EGFP/Rpl10a)JD60Jdd/J Serotonergic neurons Dougherty et al., 2013
030259 B6;FVB-Tg (Grp-EGFP/Rpl10a)JP25Htz/J Unipolar brush neurons and other Grp cells Doyle et al., 2008
NA Tg (Tie2-EGFP/Rpl10a) Endothelial cells Santhosh and Huang, 2016
aMany of the listed lines are available at The Jackson Laboratory (www.jax.org). NA, Not applicable (contact authors). More details on the expression pattern of each line are in the provided references. Many cell lines have been validated
deeply for one brain region (e.g., Neurod1 in cerebellar granule cells) but also show expression in discrete populations elsewhere in the brain. Therefore, although TRAP lines were generated independently of GENSAT, a coronal survey of
GFP/Rpl10a expression across the entire brain is now also hosted at the GENSAT website http://www.gensat.org/TRAP_listing.jsp.
Table 2. TRAP and TRAP related reporter linesa
Availability Official name Promoter Construct notes Reference
JAX:011029 B6N.129-Rpl22tm1.1Psam/J Cre-dependent, Rpl22 locus HA fusion to endogenous Rpl22 Sanz et al., 2009
JAX:022367 B6.129S4-Gt (ROSA)26Sortm1 (CAG-EGFP/Rpl10a,-birA)Wtp/J Cre-dependent, CAG, Rosa26 locus eGFP/Rpl10a; also has a Flpe-dependent BirA
biotin ligase for protein purification
Zhou et al., 2013
JAX:022386 STOCK Gt (ROSA)26Sortm1.1 (CAG-EGFP/Rpl10a,-birA)Wtp/J CAG, Rosa26 locus eGFP/Rpl10a; also has a Flpe-dependent BirA
biotin ligase for protein purification
Zhou et al., 2013
JAX:024750 B6;129S4-Gt (ROSA)26Sortm9 (EGFP/Rpl10a)Amc/J Cre-dependent, CAG, Rosa26 locus eGFP/Rpl10a Liu et al., 2014
JAX:024898 C57BL/6J-Tg (tetO-EGFP/Rpl10a)5aReij/J Tet-dependent, unknown locus eGFP/Rpl10a Drane et al., 2014
JAX:029789 B6.Cg-Gt (ROSA)26Sortm1 (CAG-HIST1H2BJ/mCherry,-EGFP/
Rpl10a)Evdr/J
Cre-dependent, CAG, Rosa26 locus Bicistronic: nuclear-mCherry and eGFP/Rpl10a Roh et al., 2017
JAX:029899 B6.Cg-Gt (ROSA)26Sortm2 (CAG-NuTRAP)Evdr/J Cre-dependent, CAG, Rosa26 locus Bicistronic: nuclear biotinylation and eGFP/Rpl10a Roh et al., 2017
JAX:030305 B6.Cg-Eef1a1tm1Rck/J Cre-dependent, Eef1a1 locus eGFP/Rpl10a Stanley et al., 2013
NA B6.129-Gt (ROSA)26Sortm1 (CAG-EGFP/Rpl10a)Brsp Cre-dependent, CAG, Rosa26 locus eGFP/Rpl10a Long et al., 2014
NA B6.FVB-Tg (Syn-NB/RPL10A)#Rck Syn, unknown locus Anti-GFP nanobody fused to Rpl10a Ekstrand et al., 2014
EM:07451 STOCK Gt (ROSA)26Sortm1 (CAG-mCherry/Rpl10a)Sten/Kctt Cre-dependent, CAG, Rosa26 locus mCherry serves at the fluorophore/affinity tag on
Rpl10a, rather than GFP
Hupe et al., 2014
aSummary of currently available lines for purification of ribosomes. JAX, Jackson ImmunoResearch Laboratories; EM, EMMAmouse repository; NA, Not applicable (contact authors).
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sion across all tagged cell types, likely in proportion to their num-
ber, amount of ribosomes, and stoichiometry of the tag, from
TRAPseq results alone it is impossible to determine whether a tran-
script is present in a subset or superset of the labeled cells. This level
of heterogeneity must be examined with other methods.
In addition to viruses, TRAP constructs can also be delivered
by electroporation at specific developmental epochs to target cell
types based on birthdate. For example, electroporation of E16 rat
cortex allowed for later TRAP analysis of Tcf4 knockdown in
layer 2/3 pyramidal neurons (Rannals et al., 2016). Electropora-
tion was also applied to study the synchronized development of
granule neurons in vivo (Yang et al., 2016) (Fig. 1D). Of course,
existing TRAP lines can also be used to study specific develop-
mental windows, provided the EGFP/RPL10A transgene is acti-
vated early enough (X. Zhu et al., 2016).
Finally, while this review is focused on mammalian nervous
systems, TRAP has been adapted for species as varied as zebrafish
(Tryon et al., 2013), Drosophila (Thomas et al., 2012), Xenopus
(Watson et al., 2012), and even plants (Juntawong et al., 2015).
Nuclear purification to examine epigenetics and
noncoding RNA
Another application of EGFP/RPL10A-expressing mouse lines
came from the observation that ribosomes are assembled in a
subnuclear structure: the nucleolus. For fluorescently tagged ver-
sions, this signal permits FACS of genetically tagged nuclei (Fig.
3A), enabling cell type-specific profiling of both chromatin states
(Kriaucionis and Heintz, 2009) and direct measures of nuclear
RNA, allowing a more direct assessment of transcription of both
mRNA and noncoding species of RNA, such as LINCs and circu-
lar RNA (Reddy et al., 2017). As ribosomes also coat the nuclear
membrane, it is possible that TRAP nuclei may be capturable by
anti-GFP, similar to the INTACT method (Deal and Henikoff,
2010). If effective, this combination could allow for direct com-
parisons from the same mice of cytoplasmic translation and nu-
clear transcription or chromatin status. Regardless, reportermice
also now exist that separately tag both ribosomes and nuclei,
which may further simplify such comparisons (Roh et al., 2017).
Cell type-specific assessment of translation
Although TRAP was used to study gene expression, since it in-
volves capture of the ribosome, it provides a unique opportunity
to study the regulation of translation in a cell type-specific man-
ner in vivo. The CNS has a remarkable degree of regulation of
translation, particularly subcellularly, where local translation of
new proteins near synapses is thought to allow alterations of local
connections in response to localized activity (Rangaraju et al.,
2017). In addition, in parallel to alternative splicing, wheremultiple
mRNA isoforms are made from a single gene, it is now recognized
that use of alternative initiation, stop codon readthrough, codon
switching, and cryptic open reading frames (ORFs) allows for mul-
tiple proteins to bemade from the samemRNA isoform (Ingolia,
2016). Furthermore, rates of translation and ribosome occu-
pancy are not equivalent for all transcripts. For example, in cul-
tured neural cells, transcript abundance, as measured by RNAseq
only, predicts60% of ribosome occupancy (Dalal et al., 2017).
The remaining 40% implies a substantial amount of transcript-
specific regulation of translation. While to date little is known
about how this process varies across cell types or in response to
disease, studies belowhighlight emerging variations of TRAP that
advance these investigations.
Translation application
Applications of TRAP to the study of local translation
A specific subset of mRNAs are enriched in dendrites and axons
(Rangaraju et al., 2017). Four recent studies adapted TRAP to test
the hypothesis that these mRNAs are bound by ribosomes and to
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Figure2. Alternative tags for purifying ribosomes. The standardTRAPprotocol (graybox) canbeadapted for usewithavarietyof ribosomal tags. A, TheRPL10A/GFP construct tags the large (60S)
subunit,which does not engagemRNAuntil initiation of translation. Thus, itwill not capture scanning small subunit (40S) particles before initiation, although itwill capture 60Sparticles unaffiliated
with mRNA. B, The HA-tagged L22 protein from the Ribotag mouse also tags the large subunit and should have similar consequences. C, The S6 protein of the small subunit is phosphorylated in
response to activity. Thus, capture of phospho-S6 should yield translating as well as potentially scanning or stalledmRNA from activated cells. It is speculated thatmRNA capture from each cell will
be proportional to the amount of S6 phosphorylation, and thus activity.D, Tagging of RPL10Awith a nanobody (NB) against GFP allows the conversion of any GFP expressing virus ormouse line into
a TRAP reagent. In this system, soluble GFP in the cell provides a linker for the tagged ribosome and the anti-GFP bead. However, as GFP is soluble ex vivo, careful consideration must be given to
blocking excess GFP.
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EYFP/RPL10Awith a Purkinje neuron-selective capsid, then har-
vested tagged ribosomes frommicrodissectedmolecular layers of
the cerebellum (Fig. 3C), where dendrites of Purkinje neurons are
found. They confirmed the translation of numerous mRNAs in
Purkinje neuron dendrites, including both rough ER and cyto-
plasmic transcripts. In a similar approach, Ainsley et al. (2014),
using a CamK2a/Tet-dependent mouse line expressing EGFP/
RPL10A in CA1 neurons, coupled microdissection of cell bodies
and dendritic layers with TRAPseq. They reported alterations
in response to fear conditioning in dendriticmRNAbound to the
ribosomes (but see also comments in PUBMED commons). Re-
gardless, microdissection-based approaches are limited to re-
gions, such as hippocampus or cerebellum, where cell bodies and
dendrites are in separable lamina. In a recent axon-focused study,
Shigeoka et al. (2016) used Ribotag with a retinal neuron-specific
Cre, followed by dissection of thalamic target regions, to identify
mRNAs on ribosomes in developing and mature axons. They
noted axonal translation is regulated across development and by
splicing-in of specific motifs. They provided clear confirmation
to a previously contentious observation that adult axons can in-
deed contain translating mRNA, although the markedly low
yields confirm consensus that ribosomes in axons aremuch lower
in abundance than in other compartments (Rangaraju et al.,
2017). Nonetheless, the presence of mRNA across development
implies an important role for generation of new protein in axons
as well. This approach should be applicable to study additional
distally projecting cells.
To access those cell types where axons or dendrites are not dis-
sectible from cell bodies, we developed a complementary approach
using biochemical fractionation, rather than dissection.We isolated
synaptoneurosome-containing fractions from all cells (Fig. 3B) and
then conducted TRAP to enrich for mRNAs bound to ribosomes
in processes of targeted cell types. The method was developed
initially to harvest locally translated mRNA from densely in-
termingled processes of cortical neurons, identifying numer-
ous enriched and depleted transcripts, likely regulated by
splicing and motifs in their 3UTRs (Ouwenga, et al., 2017). It
was also clear that non-neuronal cells contributed to these
biochemical fractions as we discovered sequence-specific lo-
calized translation in astrocytes as well (Sakers et al., 2017).
This method should be applicable to a variety of cell types, in
health and disease, and further adaptable to other fraction-
ation methods for additional subcellular compartments.
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Figure3. Adaptationsof TRAP for studying subcellular RNA localizationand regulationof translation.Additional steps canbe inserted into the standardTRAPworkflow(grayboxes) toenablenew
investigations.A, GFP/RPL10A is found in the exterior of nuclearmembrane (as it is contiguouswith the endoplasmic reticulum) and in thenucleoli. Thus, a simple nuclear fraction canbe flow-sorted
to harvest cell type-specific nuclei for either nuclear RNAseq or epigenetic studies. It is possible that direct affinity purification for GFPmight be possible, as has been shown for other nuclear tags in
NuTRAP and INTACT. B, Tissue can be prefractionated using classic protocols into specific subcellular compartments based on density to harvest portions of cells enriched in particular membrane-
enclosed fragments, such as synaptoneurosome-containing fractions (SNF), which also contain markers of peripheral astrocyte processes. The fractions can then be lysed, and cell type-specific,
subcellularly localized ribosomes can be captured with TRAP. C, Likewise, for those cells where dendrites are in lamina that are physically separable from cell bodies, microdissection enables TRAP
on each layer independently. D, TRAP’ed ribosomes can be subjected to RNase treatment to leave only those30 nucleotide fragments physically protected by the ribosome. Sequencing these
“ribosome footprints” (RF) allows for analysis of use of specific ORFs from each mRNA.
12084 • J. Neurosci., December 13, 2017 • 37(50):12079–12087 Dougherty • Build a Better Mouse TRAP
Nucleotide resolution cell type-specific analysis of translation
A drawback to all TRAP-based studies discussed above is that
they do not distinguish which protein isoform is being generated
from each mRNA. Coupling of classical ribosome footprinting
techniques withmodern high throughput RNAseq (RF-seq) allows
assessment of ORF usage across the entire transcriptome (Ingolia,
2016). Resulting insights include the unexpected abundance of
upstream ORFs in 5UTRs, alternative initiating events resulting in
N-terminal truncations and extensions, and occasional evidence
for stop-codon readthrough, allowing for C-terminal protein ex-
tensions. Thus, knowledge of a ribosome’s precise location on a
transcript can predict the protein being synthesized.
The other application of RF-seq is to calculate a ratio of RF-
seq to standard RNAseq, termed “translation efficiency,” as a
measure to identifymRNAs thatmay producemore protein than
predicted from transcript levels alone. This can be calculated
both at baseline and in response to manipulation. This identifies
transcripts that alter translation rates even when transcription is
unaltered, and has been widely applied outside of the CNS (In-
golia, 2014). In the CNS, this measure has been applied to cul-
tured neural cells simulated with KCl and identified hundreds of
transcripts that alter translation efficiency independently of
transcription alone, adding a substantial new regulatory layer to
the classically defined transcriptional response of neural cultures
to stimulation (Dalal et al., 2017). However, this analysis could
not determine which changes were occurring in neurons and
which in glia. Likewise, an RF-seq study conducted in the hip-
pocampus ofmice after fear conditioning (Cho et al., 2015) iden-
tified numerous changes in ribosome occupancy following
stimulation. However, it was not clear which changes occurred in
neurons orwhichwere due to variability in dissection (Mathew et
al., 2016).
In contrast, Gonzalez et al. (2014) successfully coupled TRAP/
Ribotag to RF in vivo to identify substantial translational changes
in a mouse model of proneural glioma, separating the ribosomes
from the tumor imitating cells and their surrounds. This combi-
nation of approaches (Fig. 3D) opens the possibility of analyzing
precise nucleotide positions, ORF usage, and translational regu-
lation in specific cell types of the brain. The authors focused
specifically on translation efficiency, defining a decrease in the
tumor cells. However, although TRAP provided access to ribo-
somes, the authors did not have a corresponding cell type-specific
total RNA measure, and thus had to rely on a deconvolution
algorithm from bulk RNAseq for their assessment of transcrip-
tion in each cell type, an approach that will be challenging for
more rare cell types. However, parallel studies profiling the same
mouse lines with TRAP and cell type-specific nuclear FACs/
RNAseq (Kriaucionis and Heintz, 2009; Reddy et al., 2017), or
new specialized reporter lines (Roh et al., 2017) should simplify
these analyses. Thus, the field is on the verge of being able to
address, in a cell type-specific manner, regulation of translation
in vivo.
Thus far, the in-brain RF studies have not taken advantage of
the ability to study alternativeORFusage. This is perhaps because
upstreamORFs and alternative initiation events normally require
for their detection use of inhibitors to stall the ribosomes at ini-
tiation.While these inhibitors canwork in vivo, at least in the liver
(Gao et al., 2015), they have not been thoroughly tested for the
brain.
Future challenges and opportunities
One of the clearest challenges to TRAP remains the nature of the
method as an enrichment, rather than a perfect purification, of
the RNA from the targeted cells (Dougherty et al., 2010; Okaty et
al., 2011). Analysis of “marker” genes from nontargeted popula-
tions (e.g., assessment of the glial GFAP mRNA from a neuronal
TRAP sample) typically shows depletion by TRAP, but not a
complete absence. Thus, inclusion of comparison groups such as
an input RNAseq and negative controls (for example, sequencing
TRAP from wild-type mice, as was done by Shigeoka (2016),
remains essential to defining transcripts confidently enriched in
the targeted cells. However, this requirement increases the num-
ber of samples required for sequencing as well as the complexity
of the analysis and interpretation. It also means that negative
results should be interpreted with caution: a transcript below the
level of noise may still be expressed in the cell type, albeit at a
much lower level than the surrounding tissue. This nonspecific
background could have many sources from the technical (non-
specific association of mRNAs and beads in vitro) to the biologi-
cal (movement ofmRNA or ribosomes between cell types in vivo,
or legitimate but low-level expression of the transgene). It is clear
that further development is needed, and direct comparisons of
background under different technical conditions would be useful
to determine which ribosomal protein, antibody, affinity tag,
crosslinking reagent, or transgene expression level might be op-
timal for improving signal-to-noise.
Nonetheless, TRAP has now been adopted for large and small
roles in dozens of studies, and adapted to a variety of new appli-
cations outlined here. Straightforward next advances would be
combinations of these. As outlined in Figures 1–3, each of the
variations impacts different steps of the protocol: thus, combin-
ing subsets (e.g., RF-TRAP with SynapTRAP to study alterative
translation in neurites) should be feasible. The ability of ex-
pandedTRAPmethods to enhance the cell specificity of advanced
molecular techniques will only continue as new sequencing-
based methods of translation are created. This flexibility in the
expanding toolkit will enable integration with a wide range of
studies, hopefully permitting both a deeper analysis of candidate
cell types and a better understanding of the regulation of transla-
tion in health and disease.
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